vs

Side-by-side financial comparison of Fastly, Inc. (FSLY) and Vericel Corp (VCEL). Click either name above to swap in a different company.

Fastly, Inc. is the larger business by last-quarter revenue ($172.6M vs $92.9M, roughly 1.9× Vericel Corp). Vericel Corp runs the higher net margin — 25.0% vs -9.0%, a 34.0% gap on every dollar of revenue. On growth, Vericel Corp posted the faster year-over-year revenue change (23.3% vs 22.8%). Vericel Corp produced more free cash flow last quarter ($12.8M vs $12.2M). Over the past eight quarters, Vericel Corp's revenue compounded faster (34.6% CAGR vs 13.7%).

Fastly, Inc. is an American company based in San Francisco, which describes itself as a cloud computing company. Fastly provides content delivery network services, image optimization, and load balancing services. Fastly's cloud security services include denial-of-service attack protection, bot mitigation, and a web application firewall.

Vericel Corporation is a publicly traded American biopharmaceutical company which was known prior to October 2014 as Aastrom Bio. Aastrom Bio was formed in 1989 in Ann Arbor, Michigan.

FSLY vs VCEL — Head-to-Head

Bigger by revenue
FSLY
FSLY
1.9× larger
FSLY
$172.6M
$92.9M
VCEL
Growing faster (revenue YoY)
VCEL
VCEL
+0.5% gap
VCEL
23.3%
22.8%
FSLY
Higher net margin
VCEL
VCEL
34.0% more per $
VCEL
25.0%
-9.0%
FSLY
More free cash flow
VCEL
VCEL
$584.0K more FCF
VCEL
$12.8M
$12.2M
FSLY
Faster 2-yr revenue CAGR
VCEL
VCEL
Annualised
VCEL
34.6%
13.7%
FSLY

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
FSLY
FSLY
VCEL
VCEL
Revenue
$172.6M
$92.9M
Net Profit
$-15.5M
$23.2M
Gross Margin
61.4%
78.7%
Operating Margin
-8.7%
24.1%
Net Margin
-9.0%
25.0%
Revenue YoY
22.8%
23.3%
Net Profit YoY
52.9%
17.3%
EPS (diluted)
$-0.10
$0.46

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FSLY
FSLY
VCEL
VCEL
Q4 25
$172.6M
$92.9M
Q3 25
$158.2M
$67.5M
Q2 25
$148.7M
$63.2M
Q1 25
$144.5M
$52.6M
Q4 24
$140.6M
$75.4M
Q3 24
$137.2M
$57.9M
Q2 24
$132.4M
$52.7M
Q1 24
$133.5M
$51.3M
Net Profit
FSLY
FSLY
VCEL
VCEL
Q4 25
$-15.5M
$23.2M
Q3 25
$-29.5M
$5.1M
Q2 25
$-37.5M
$-553.0K
Q1 25
$-39.1M
$-11.2M
Q4 24
$-32.9M
$19.8M
Q3 24
$-38.0M
$-901.0K
Q2 24
$-43.7M
$-4.7M
Q1 24
$-43.4M
$-3.9M
Gross Margin
FSLY
FSLY
VCEL
VCEL
Q4 25
61.4%
78.7%
Q3 25
58.4%
73.5%
Q2 25
54.5%
73.7%
Q1 25
53.2%
69.0%
Q4 24
53.4%
77.6%
Q3 24
54.5%
71.9%
Q2 24
55.1%
69.5%
Q1 24
54.8%
68.9%
Operating Margin
FSLY
FSLY
VCEL
VCEL
Q4 25
-8.7%
24.1%
Q3 25
-18.2%
5.1%
Q2 25
-24.8%
-3.2%
Q1 25
-26.4%
-24.3%
Q4 24
-24.4%
24.5%
Q3 24
-29.6%
-4.3%
Q2 24
-35.3%
-11.5%
Q1 24
-34.6%
-10.7%
Net Margin
FSLY
FSLY
VCEL
VCEL
Q4 25
-9.0%
25.0%
Q3 25
-18.6%
7.5%
Q2 25
-25.2%
-0.9%
Q1 25
-27.1%
-21.4%
Q4 24
-23.4%
26.3%
Q3 24
-27.7%
-1.6%
Q2 24
-33.0%
-8.9%
Q1 24
-32.5%
-7.5%
EPS (diluted)
FSLY
FSLY
VCEL
VCEL
Q4 25
$-0.10
$0.46
Q3 25
$-0.20
$0.10
Q2 25
$-0.26
$-0.01
Q1 25
$-0.27
$-0.23
Q4 24
$-0.23
$0.40
Q3 24
$-0.27
$-0.02
Q2 24
$-0.32
$-0.10
Q1 24
$-0.32
$-0.08

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FSLY
FSLY
VCEL
VCEL
Cash + ST InvestmentsLiquidity on hand
$361.8M
$137.5M
Total DebtLower is stronger
Stockholders' EquityBook value
$929.6M
$354.6M
Total Assets
$1.5B
$488.0M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FSLY
FSLY
VCEL
VCEL
Q4 25
$361.8M
$137.5M
Q3 25
$342.9M
$135.4M
Q2 25
$321.2M
$116.9M
Q1 25
$307.3M
$112.9M
Q4 24
$295.9M
$116.2M
Q3 24
$308.2M
$101.7M
Q2 24
$311.8M
$102.5M
Q1 24
$329.5M
$110.6M
Stockholders' Equity
FSLY
FSLY
VCEL
VCEL
Q4 25
$929.6M
$354.6M
Q3 25
$937.0M
$321.9M
Q2 25
$942.6M
$306.8M
Q1 25
$957.0M
$295.5M
Q4 24
$965.3M
$292.0M
Q3 24
$969.5M
$257.5M
Q2 24
$981.2M
$243.0M
Q1 24
$991.8M
$233.9M
Total Assets
FSLY
FSLY
VCEL
VCEL
Q4 25
$1.5B
$488.0M
Q3 25
$1.5B
$453.3M
Q2 25
$1.5B
$435.6M
Q1 25
$1.4B
$424.6M
Q4 24
$1.5B
$432.7M
Q3 24
$1.5B
$390.4M
Q2 24
$1.5B
$376.8M
Q1 24
$1.5B
$356.7M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FSLY
FSLY
VCEL
VCEL
Operating Cash FlowLast quarter
$22.4M
$15.0M
Free Cash FlowOCF − Capex
$12.2M
$12.8M
FCF MarginFCF / Revenue
7.1%
13.8%
Capex IntensityCapex / Revenue
5.9%
2.4%
Cash ConversionOCF / Net Profit
0.65×
TTM Free Cash FlowTrailing 4 quarters
$65.8M
$24.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FSLY
FSLY
VCEL
VCEL
Q4 25
$22.4M
$15.0M
Q3 25
$28.9M
$22.1M
Q2 25
$25.8M
$8.2M
Q1 25
$17.3M
$6.6M
Q4 24
$5.2M
$22.2M
Q3 24
$5.0M
$10.2M
Q2 24
$-4.9M
$18.5M
Q1 24
$11.1M
$7.2M
Free Cash Flow
FSLY
FSLY
VCEL
VCEL
Q4 25
$12.2M
$12.8M
Q3 25
$22.9M
$19.5M
Q2 25
$15.9M
$81.0K
Q1 25
$14.7M
$-7.6M
Q4 24
$251.0K
$8.5M
Q3 24
$3.0M
$-9.2M
Q2 24
$-6.7M
$1.8M
Q1 24
$9.5M
$-6.8M
FCF Margin
FSLY
FSLY
VCEL
VCEL
Q4 25
7.1%
13.8%
Q3 25
14.5%
28.8%
Q2 25
10.7%
0.1%
Q1 25
10.2%
-14.5%
Q4 24
0.2%
11.2%
Q3 24
2.2%
-15.9%
Q2 24
-5.1%
3.4%
Q1 24
7.1%
-13.3%
Capex Intensity
FSLY
FSLY
VCEL
VCEL
Q4 25
5.9%
2.4%
Q3 25
3.8%
3.9%
Q2 25
6.6%
12.9%
Q1 25
1.8%
27.0%
Q4 24
3.5%
18.3%
Q3 24
1.5%
33.5%
Q2 24
1.3%
31.8%
Q1 24
1.2%
27.3%
Cash Conversion
FSLY
FSLY
VCEL
VCEL
Q4 25
0.65×
Q3 25
4.35×
Q2 25
Q1 25
Q4 24
1.12×
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

FSLY
FSLY

Network Services$130.8M76%
Security$35.4M21%
Other$6.4M4%

VCEL
VCEL

MACI Implants And Kits$84.1M90%
Other$8.8M10%

Related Comparisons